DE60002484T2 - Zusammensetzung die einen alpha-amylase inhibitor und mindestens eine physiologisch akzeptabele komponente, der die intestinale absorption von "fast sugars" reduzieren kann, enthält - Google Patents

Zusammensetzung die einen alpha-amylase inhibitor und mindestens eine physiologisch akzeptabele komponente, der die intestinale absorption von "fast sugars" reduzieren kann, enthält Download PDF

Info

Publication number
DE60002484T2
DE60002484T2 DE60002484T DE60002484T DE60002484T2 DE 60002484 T2 DE60002484 T2 DE 60002484T2 DE 60002484 T DE60002484 T DE 60002484T DE 60002484 T DE60002484 T DE 60002484T DE 60002484 T2 DE60002484 T2 DE 60002484T2
Authority
DE
Germany
Prior art keywords
composition
weight
inhibitor
fat
inulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60002484T
Other languages
German (de)
English (en)
Other versions
DE60002484D1 (de
Inventor
Nils Christian Sentrum MORTENSEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MED EQ AS SENTRUM
MED-EQ AS
Original Assignee
MED EQ AS SENTRUM
MED-EQ AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MED EQ AS SENTRUM, MED-EQ AS filed Critical MED EQ AS SENTRUM
Publication of DE60002484D1 publication Critical patent/DE60002484D1/de
Application granted granted Critical
Publication of DE60002484T2 publication Critical patent/DE60002484T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Enzymes And Modification Thereof (AREA)
DE60002484T 1999-09-08 2000-09-08 Zusammensetzung die einen alpha-amylase inhibitor und mindestens eine physiologisch akzeptabele komponente, der die intestinale absorption von "fast sugars" reduzieren kann, enthält Expired - Fee Related DE60002484T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9921229.2A GB9921229D0 (en) 1999-09-08 1999-09-08 Compositions
GB9921229 1999-09-08
PCT/GB2000/003472 WO2001017369A1 (en) 1999-09-08 2000-09-08 Composition comprising an alpha-amylase inhibitor and at least one physiologically acceptable compound capable of reducing intestinal absorption of 'fast sugars'

Publications (2)

Publication Number Publication Date
DE60002484D1 DE60002484D1 (de) 2003-06-05
DE60002484T2 true DE60002484T2 (de) 2004-03-18

Family

ID=10860574

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60002484T Expired - Fee Related DE60002484T2 (de) 1999-09-08 2000-09-08 Zusammensetzung die einen alpha-amylase inhibitor und mindestens eine physiologisch akzeptabele komponente, der die intestinale absorption von "fast sugars" reduzieren kann, enthält

Country Status (14)

Country Link
EP (1) EP1213972B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003508467A (cg-RX-API-DMAC7.html)
KR (1) KR100594520B1 (cg-RX-API-DMAC7.html)
AT (1) ATE238689T1 (cg-RX-API-DMAC7.html)
AU (1) AU777044B2 (cg-RX-API-DMAC7.html)
CA (1) CA2383720A1 (cg-RX-API-DMAC7.html)
DE (1) DE60002484T2 (cg-RX-API-DMAC7.html)
DK (1) DK1213972T3 (cg-RX-API-DMAC7.html)
ES (1) ES2199174T3 (cg-RX-API-DMAC7.html)
GB (2) GB9921229D0 (cg-RX-API-DMAC7.html)
NO (1) NO314922B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ518167A (cg-RX-API-DMAC7.html)
PT (1) PT1213972E (cg-RX-API-DMAC7.html)
WO (1) WO2001017369A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601528B1 (en) 2000-12-23 2009-10-13 Elan Pharmaceuticals, Inc. Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in alzheimer's disease
US7217556B1 (en) 2000-12-23 2007-05-15 Pfizer Inc Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in Alzheimer's disease
US7384773B1 (en) 2001-05-10 2008-06-10 Pfizer Inc Crystal of HIV protease-cleaved human beta secretase and method for crystallization thereof
US6797287B2 (en) 2001-09-25 2004-09-28 Pharmachem Laboratories, Inc. Phaseolamin compositions and methods for using the same
US7108869B2 (en) 2002-11-07 2006-09-19 Access Business Group International Llc Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors
ITMI20030391A1 (it) * 2003-03-04 2004-09-05 S I I T S R L Servizio Internaz Ionale Imballa Formulazioni anticarie a base di faseolamina.
ITMI20052450A1 (it) * 2005-12-22 2007-06-23 Indena Spa Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono
JP5285852B2 (ja) * 2006-12-28 2013-09-11 株式会社ファンケル Dfaiiiの製造方法及びdfaiii高含有植物エキス
US20100330137A1 (en) * 2008-03-10 2010-12-30 Mauro Mantovani High bioavailability formulation of mangosteen and manufacturing process thereof
CN102292093B (zh) * 2009-02-02 2015-01-28 莱拉营养食品有限公司 用于代谢综合症控制的选自绒毛戴星草和莽吉柿的混合物
JP2011079752A (ja) * 2009-10-05 2011-04-21 Kracie Home Products Ltd 膵リパーゼ阻害剤並びにそれを含有する飲食品組成物及び医薬品組成物
CN103478738B (zh) * 2013-09-17 2016-02-10 深圳太太药业有限公司 一种具有减肥塑身及体重管理作用的组合物
EP3193899A1 (en) * 2014-09-19 2017-07-26 Nestec S.A. Methods and formulations for reducing absorption of carbohydrates in a companion animal
CN106036342A (zh) * 2016-06-14 2016-10-26 安徽平唐微食疗科技有限公司 适合于糖尿病人群食用的膳食补充固体饮料及其制备方法
IT201700078389A1 (it) * 2017-07-13 2019-01-13 Mv Medical Solutions Composizione utile nella prevenzione o trattamento degli stati di malassorbimento secondari a chirurgia bariatrica in soggetti obesi.
EP3975755A1 (en) * 2019-05-24 2022-04-06 Cosucra Groupe Warcoing S.A. Composition comprising inulin and protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4010258A (en) * 1974-03-15 1977-03-01 Ajinomoto Co., Inc. Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus
JP2757405B2 (ja) * 1988-12-09 1998-05-25 日清製粉株式会社 小麦から得られるα−アミラーゼインヒビターを含有するダイエット剤
US5612039A (en) * 1994-03-14 1997-03-18 Nini E. Policappelli Dietary supplement
JP2002535288A (ja) * 1999-01-22 2002-10-22 ウンツァ ディ マリア カルメラ マラッツィータ エッセ.ア.エッセ. リポタンパク質複合体およびそれらを含む組成物

Also Published As

Publication number Publication date
NO314922B1 (no) 2003-06-16
AU7026900A (en) 2001-04-10
KR100594520B1 (ko) 2006-07-19
GB2364498A (en) 2002-01-30
PT1213972E (pt) 2003-09-30
AU777044B2 (en) 2004-09-30
ATE238689T1 (de) 2003-05-15
DE60002484D1 (de) 2003-06-05
NZ518167A (en) 2003-03-28
CA2383720A1 (en) 2001-03-15
ES2199174T3 (es) 2004-02-16
NO20021160L (no) 2002-03-27
EP1213972A1 (en) 2002-06-19
JP2003508467A (ja) 2003-03-04
KR20020045605A (ko) 2002-06-19
DK1213972T3 (da) 2003-08-18
GB9921229D0 (en) 1999-11-10
EP1213972B1 (en) 2003-05-02
NO20021160D0 (no) 2002-03-08
WO2001017369A1 (en) 2001-03-15
GB0127158D0 (en) 2002-01-02

Similar Documents

Publication Publication Date Title
DE69916288T2 (de) Lipasehemmer und chitosan enthaltende arzneimittel
DE3876054T2 (de) Psyllium enthaltende kuchen.
DE60210603T2 (de) Duales ballaststoffsystem und seine verwendung
DE60220182T2 (de) Alkoholfreies getränkeersatz
DE69533593T2 (de) Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.
DE3873800T2 (de) Zusammensetzungen zur behandlung von hypercholesterinaemie.
DE2919449C2 (de) Diätisches Mittel zur natürlichen Verdauungsregelung
DE69924999T2 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
DE60118387T2 (de) Verbesserte pädiatrische zusammensetzung und verfahren zur ernährung und verbesserung der toleranz
DE60309169T2 (de) Verwendung vom pullulan als langsam verdauliches kohlenhydrat
DE60209442T2 (de) Phaseolamin-Zusammensetzungen und Verfahren zur Anwendung derselben
DE60207877T2 (de) Zusammensetzung enthaltend Procyanidine zur Verminderung des Appetits bei Säugetieren
SK16399A3 (en) Compositions of plant carbohydrates as dietary supplements
EP1213972B1 (en) Composition comprising an alpha-amylase inhibitor and at least one physiologically acceptable compound capable of reducing intestinal absorption of "fast sugars"
DE102010038644A1 (de) Diätetische, nahrungsergänzende Zusammensetzung
DE69232126T3 (de) Aufnehmbare Zubereitungen enthaltend wasserlösliche, hochviskose Cellulosether
AT504440A1 (de) Ballaststoff
DE69809375T2 (de) Antikrebs-Zubereitung
US20050003027A1 (en) Chemical composition and method to bind fat, enhance metabolization, and aid digestion
DE60037197T2 (de) Verwendung funktioneller oraler präparate
EP1383523B1 (de) Kombinationspräparat zur behandlung des diabetes mellitus
DE102020109099A1 (de) Ergänzungsfuttermittel für Schweine
US5910317A (en) Mixed compositions for treating hypercholesterolemia
WO2012059090A1 (de) Etacrynsäure zur verwendung bei der behandlung von lebensmittelempfindlichkeitsstörungen
CN114028504A (zh) 具有降糖、降脂、降血压功能的复方全谷物咀嚼片及其制备方法和应用

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee